Guardian Pharmacy Services, Inc.'s Quiet Period Will End on November 5th (NYSE:GRDN)

Guardian Pharmacy Services' (NYSE:GRDN - Get Free Report) quiet period is set to expire on Tuesday, November 5th. Guardian Pharmacy Services had issued 8,000,000 shares in its initial public offering on September 26th. The total size of the offering was $112,000,000 based on an initial share price of $14.00. During the company's quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Analysts Set New Price Targets

A number of analysts recently issued reports on GRDN shares. Raymond James began coverage on Guardian Pharmacy Services in a research note on Monday, October 21st. They set an "outperform" rating and a $21.00 target price for the company. Stephens assumed coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They set an "overweight" rating and a $21.00 price objective for the company. Finally, Truist Financial started coverage on shares of Guardian Pharmacy Services in a research report on Monday, October 21st. They issued a "buy" rating and a $22.00 price objective on the stock.

Guardian Pharmacy Services Trading Up 2.0 %

GRDN traded up $0.35 on Tuesday, hitting $17.99. 52,661 shares of the company were exchanged, compared to its average volume of 146,937. Guardian Pharmacy Services has a 12 month low of $14.16 and a 12 month high of $20.10.

Insiders Place Their Bets

In other Guardian Pharmacy Services news, Director Thomas J. Salentine, Jr. bought 35,714 shares of Guardian Pharmacy Services stock in a transaction dated Friday, September 27th. The stock was bought at an average price of $14.00 per share, with a total value of $499,996.00. Following the completion of the transaction, the director now owns 35,714 shares in the company, valued at $499,996. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Institutional Investors Weigh In On Guardian Pharmacy Services

Institutional investors and hedge funds have recently bought and sold shares of the company. Seven Grand Managers LLC acquired a new position in Guardian Pharmacy Services during the third quarter valued at approximately $2,515,000. Allspring Global Investments Holdings LLC bought a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at $5,460,000. Finally, Stephens Inc. AR acquired a new position in shares of Guardian Pharmacy Services during the 3rd quarter worth $189,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.